LEADER 04202nam 2200589 450 001 9910484403303321 005 20230424163629.0 010 $a3-030-68321-4 024 7 $a10.1007/978-3-030-68321-4 035 $a(CKB)4100000011918842 035 $a(DE-He213)978-3-030-68321-4 035 $a(MiAaPQ)EBC6607526 035 $a(Au-PeEL)EBL6607526 035 $a(OCoLC)1250346027 035 $a(PPN)255885180 035 $a(EXLCZ)994100000011918842 100 $a20220119d2021 uy 0 101 0 $aeng 135 $aurnn#008mamaa 181 $ctxt$2rdacontent 182 $cc$2rdamedia 183 $acr$2rdacarrier 200 00$aOvercoming antimicrobial resistance of the skin /$fStephen K. Tyring [and three others] editors 205 $a1st ed. 2021. 210 1$aCham, Switzerland :$cSpringer,$d[2021] 210 4$d©2021 215 $a1 online resource (XVI, 255 p. 85 illus., 78 illus. in color.) 225 1 $aUpdates in Clinical Dermatology 311 $a3-030-68320-6 327 $aSection I: Emerging Bacterial Resistance to Antibiotics -- Ch 1: Mechanisms of Bacterial Resistance -- Ch 2: Emerging Bacterial Infections -- Ch 3: Re-Emerging Bacterial Infections of the Skin -- Section II: Emerging Resistance to Antivirals -- Ch 4: Mechanisms of Nonretroviral Resistance -- Ch 5: Mechanisms of Retroviral Resistance -- Ch 6: Emerging Viral Infections -- Ch 7: Re-Emerging Viral Infections - Implications of Lack of Vaccination -- Section III: Emerging Resistance to Antifungals -- Ch 8: Mechanisms of Antifungal Resistance -- Ch 9: Emerging and Re-Emerging Fungal Infections -- Section IV: Emerging Resistance to Drugs for Protozoan and Helminth Infections -- Ch 10: Mechanisms of Anti-Protozoan/Helminth Drug Resistance -- Ch 11: Emerging and Re-Emerging Protozoan/Helminth Infections -- Section V: Innovative Therapies on the Forefront -- Ch 12: Phage Therapy -- Ch 13: The Role of Biofilms and the Microbiome -- Ch 14: New Classes of Broad-Spectrum Antibiotics and New Mechanisms of Delivery -- Ch 15: Phytocompounds -- Ch 16: Summary: Overcoming Antimicrobial Resistance of the Skin. . 330 $aThis book is a thorough, practical review of the challenges facing clinicians treating skin microbes and how to combat these therapeutic dilemmas. It expresses the critical public health concern of antimicrobial resistance and shows how microorganisms are developing the ability to halt the progress of antimicrobials like antibiotics, antivirals, and antifungals. Chapters are grouped together in five sections for ease of use. The first three sections of the book convey foundational information on the mechanisms of antibiotics, antivirals, and antifungals resistance, as well as the implications of lack of vaccination. The fourth section then turns to the specifics of drug resistance for protozoan and helminth infections focusing primarily on initial and subsequent resistance to treatment. The book closes with a discussion on the potential solutions of innovative therapy including new delivery mechanisms, broad-spectrum antibiotics, phytocompounds, and biofilms. Chapters feature magnified, microscopic photos for identifying structures as they appear on the skin. Part of the Updates in Clinical Dermatology series, Overcoming Antimicrobial Resistance of the Skin is an important resource relevant during the COVID-19 pandemic, and is written for all medical healthcare professionals. 410 0$aUpdates in clinical dermatology. 606 $aSkin$xDiseases$xTreatment 606 $aSkin$xDiseases$xMicrobiology 606 $aMalalties de la pell$2thub 606 $aMicrobiologia$2thub 606 $aQuimioteràpia$2thub 608 $aLlibres electrònics$2thub 615 0$aSkin$xDiseases$xTreatment. 615 0$aSkin$xDiseases$xMicrobiology. 615 7$aMalalties de la pell 615 7$aMicrobiologia 615 7$aQuimioteràpia 676 $a616.506 702 $aTyring$b Stephen K$g(Stephen Keith), 801 0$bMiAaPQ 801 1$bMiAaPQ 801 2$bMiAaPQ 906 $aBOOK 912 $a9910484403303321 996 $aOvercoming Antimicrobial Resistance of the Skin$92005826 997 $aUNINA